Patents-Review.com
ClassID:

169358 ⎘

G01N33/944 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors; Neurotransmitters Acetylcholine

Recent Application in this class:
#1
20260147006
2026-05-28

SCREENING METHOD

 #2
20260023089
2026-01-22

GENETICALLY ENCODED BIOLUMINESCENT SENSORS

 #3
20250283872
2025-09-11

EXPRESSION SYSTEMS FOR THE ALPHA2ALPHA5BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF

 #4
20250277784
2025-09-04

EXPRESSION SYSTEMS FOR THE ALPHA6BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF

 #5
20220229078
2022-07-21

OVERACTIVE BLADDER DIAGNOSTIC APPARATUS AND METHODS

 #6
20220099685
2022-03-31

METHOD

 #7
20210389336
2021-12-16

Method for simultaneous analysis of neurotransmitters and their metabolites based on derivatization

 #8
20200182850
2020-06-11

Method for measuring alpha value of muscarinic M1 receptor positive allosteric modulators

 #9
20200011885
2020-01-09

A CELL-BASED ASSAY AND KITS FOR ASSESSING SERUM ANTICHOLINERGIC ACTIVITY

 #10
20180143213
2018-05-24

METHODS FOR THE DETECTION OF ANTIBODIES AGAINST MEMBERS OF THE CARDIAC RECEPTOR FAMILY

 #11
20160310619
2016-10-27

SCREENING METHODS FOR ACETYLCHOLINE RELATED BIOACTIVE MATERIALS USING INHERITED COLOR PREFERENCE OF FISH

 #12
20160022658
2016-01-28

PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE

 #13
20150338394
2015-11-26

Method for screening drugs and animal model for same

 #14
20150299276
2015-10-22

α-conotoxin peptide, pharmaceutical composition and use thereof

 #15
20150158921
2015-06-11

αO-superfamily conotoxin peptide, pharmaceutical composition and use thereof

 #16
20120270799
2012-10-25

Method of identifying a candidate compound which may inhibit α9-nAchR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells

 #17
20110294698
2011-12-01

PROCESS FOR IDENTIFYING DRUGS FOR TREATING GASTROESOPHAGEAL REFLUX

 #18
20110281278
2011-11-17

High throughput assay for discovering new inhibitors of the GIRK1/4 channel

 #19
20110190314
2011-08-04

Pharmaceutical compositions and their methods of use

 #20
20100129291
2010-05-27

Nicotinic desensitizers and methods of selecting, testing, and using them

 #21
20100040638
2010-02-18

Smoking cessation kit and method

 #22
20090203616
2009-08-13

Methods for treating pain and screening analgesic compounds

 #23
20080167286
2008-07-10

Pharmaceutical compositions and their methods of use

 #24
20080132551
2008-06-05

Positive allosteric modulators of the nicotinic acetylcholine receptor

 #25
20070259391
2007-11-08

Assessment of the effects of topical administration of chemodenervating pharmaceuticals

 #26
20070219130
2007-09-20

Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction

 #27
20070191290
2007-08-16

Smilagenin and its use

 #28
20070184490
2007-08-09

Neuronal nicotinic receptor ligands and their use

 #29
20060263352
2006-11-23

Quantification of botulinum toxin

 #30
20060182817
2006-08-17

Steroidal sapogenins and their derivatives for treating Alzheimer's disease

 #31
20060142349
2006-06-29

Methods of modulating the activities of alpha-7 nicotinic acetylcholine receptor

 #32
20060142188
2006-06-29

Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof

 #33
20060099600
2006-05-11

Novel acetylcholine transporter

 #34
20050287663
2005-12-29

DNA encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and a recombinant cell line expressing a functional human alpha7 subunit of neuronal nicotinic acetylcholine receptor

 #35
20050170360
2005-08-04

Variant neuronal nicotinic alpha-7 receptor and methods of use

 #36
20050143285
2005-06-30

Methods for identifying agents that modulate LGIC receptor activity

 #37
20050004025
2005-01-06

Use of SLURP-1 compositions for treating schizophrenia